| Full name: ELFN1 antisense RNA 1 | Alias Symbol: MYCLo-2 | ||
| Type: non-coding RNA | Cytoband: 7p22.3 | ||
| Entrez ID: 101927125 | HGNC ID: HGNC:39071 | Ensembl Gene: ENSG00000236081 | OMIM ID: |
| Drug and gene relationship at DGIdb | |||
Expression of ELFN1-AS1:
| Dataset | Gene | EntrezID | Probe | Log2FC | Adj.pValue | Expression |
|---|---|---|---|---|---|---|
| GSE17351 | ELFN1-AS1 | 101927125 | 231443_at | 0.0164 | 0.9609 | |
| GSE26886 | ELFN1-AS1 | 101927125 | 231443_at | 0.3286 | 0.0423 | |
| GSE45670 | ELFN1-AS1 | 101927125 | 231443_at | 0.0576 | 0.6225 | |
| GSE53622 | ELFN1-AS1 | 101927125 | 96106 | 0.5213 | 0.0057 | |
| GSE53624 | ELFN1-AS1 | 101927125 | 96106 | 0.3114 | 0.0441 | |
| GSE63941 | ELFN1-AS1 | 101927125 | 231443_at | 0.5688 | 0.1002 | |
| GSE77861 | ELFN1-AS1 | 101927125 | 231443_at | 0.0225 | 0.8670 |
Upregulated datasets: 0; Downregulated datasets: 0.
Survival by ELFN1-AS1 expression:
Note: Click image to view full size file.
Copy number change of ELFN1-AS1:
No record found for this gene.
Somatic mutations of ELFN1-AS1:
Generating mutation plots.
Highly correlated genes for ELFN1-AS1:
Showing all 17 correlated genes with mean PCC>0.5.
| Gene1 | Gene2 | Mean PCC | Num. Datasets | Num. PCC<0 | Num. PCC>0.5 |
|---|---|---|---|---|---|
| ELFN1-AS1 | CLDN19 | 0.689604 | 3 | 0 | 3 |
| ELFN1-AS1 | OAS2 | 0.639256 | 3 | 0 | 3 |
| ELFN1-AS1 | ANKRD45 | 0.634429 | 3 | 0 | 3 |
| ELFN1-AS1 | LAIR2 | 0.574727 | 4 | 0 | 3 |
| ELFN1-AS1 | IFNL2 | 0.56438 | 3 | 0 | 3 |
| ELFN1-AS1 | LINC01352 | 0.548475 | 3 | 0 | 3 |
| ELFN1-AS1 | TRIM51 | 0.543238 | 3 | 0 | 3 |
| ELFN1-AS1 | ASB12 | 0.542636 | 4 | 0 | 3 |
| ELFN1-AS1 | ZNF214 | 0.540399 | 3 | 0 | 3 |
| ELFN1-AS1 | RHEBL1 | 0.540238 | 4 | 0 | 3 |
| ELFN1-AS1 | GPX5 | 0.539448 | 3 | 0 | 3 |
| ELFN1-AS1 | FAM181A | 0.532661 | 3 | 0 | 3 |
| ELFN1-AS1 | CD7 | 0.525734 | 5 | 0 | 3 |
| ELFN1-AS1 | ZNF384 | 0.524311 | 4 | 0 | 3 |
| ELFN1-AS1 | CD79A | 0.516579 | 3 | 0 | 3 |
| ELFN1-AS1 | NRSN1 | 0.510751 | 5 | 0 | 3 |
| ELFN1-AS1 | HPX | 0.508354 | 4 | 0 | 3 |
For details and further investigation, click here

